Broncho-Vaxom for children 10 sachets

Trade name:

Broncho-vaxom for children

Each sachet contains:

OM-85 lyophilisate 20 mg

containing 3.5 mg lyophilisate of bacterial lysates: Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Moraxella catarrhalis.

Auxiliary components:

Antiox, propyl gallate, glutamate, sachet excipients.

Properties:

Immunostimulating drug of bacterial origin. Causes an immune response of the mucous membrane of the digestive tract. The effect is most pronounced in Peyer’s patches (PB) of the small intestine. Antigen presenting cells (APCs) in PB are activated by the drug and subsequently stimulate the cells responsible for specific immunity.

When using the drug, an increase in the number of circulating B-lymphocytes is observed. After stimulation of B-lymphocytes, there is an increase in the production of polyclonal antibodies, especially serum IgG and IgA secreted by the respiratory mucosa and saliva. These antibodies are the first line of defense against a range of infectious agents (viruses and bacteria).

The drug has a powerful stimulating effect on most types of leukocytes, as evidenced by an increase in the number of myeloid and lymphoid cells, as well as a selective increase in the expression of receptors on their surface.

Taken together, these data confirm that the drug triggers biological reactions that enhance the body’s immune defense against infection.

Clinically, Broncho-Vaxom® for children reduces the frequency of acute respiratory tract infections, reduces the duration of their course, reduces the likelihood of exacerbation of chronic bronchitis, and also increases the body’s resistance to infections of the respiratory system. This reduces the need for the use of other drugs, especially antibiotics.

Indications:

Children aged 6 months to 12 years:

– prevention of recurrent respiratory infections and exacerbations of chronic bronchitis;

– treatment of acute respiratory tract infections (as part of complex therapy).

Dosage and administration:

For the treatment of acute and exacerbation of chronic respiratory infections: dissolve 1 sachet in half a glass of water, juice, milk and take daily in the morning on an empty stomach until symptoms disappear, but not less than 10 days. If it is necessary to conduct antibiotic therapy with Broncho-Vax® for children, it should be taken in combination with an antibiotic from the beginning of treatment.

The duration of treatment should be determined by the doctor, based on the state of health of the patient.

In order to prevent exacerbations and maintenance therapy: 1 sachet of Broncho-Vaxom® for children daily in the morning on an empty stomach. The course includes 3 cycles, each of which consists of a daily intake of 1 capsule for 10 days, the interval between cycles is 20 days.

Contraindications:

Hypersensitivity to the components of the drug.

Precautionary measures:

Broncho-Vaxom® for children should not be used in children under 6 months of age.

The components of the drug can cause hypersensitivity reactions. In case of persistent gastrointestinal disturbances, skin reaction, respiratory disorders or other symptoms of drug intolerance, treatment should be discontinued, because. These symptoms are manifestations of allergic reactions.

Side effects:

From the digestive system: often – diarrhea, abdominal pain; unknown – vomiting, nausea.

From the nervous system: unknown – headache.

From the respiratory system: often – cough.

Dermatological reactions: often – rash.

Allergic reactions: infrequently – hypersensitivity reactions (rash erythematous, rash generalized, erythema, swelling of the eyelids, swelling of the face, peripheral edema, swelling of the face, itching, generalized itching, shortness of breath); unknown – urticaria, Quincke’s edema.

Storage method:

Store at a temperature not exceeding 30 degrees.

Package:

The cardboard box contains 10 sachets, paper instructions.